AI and machine learning are revolutionizing peptide and protein drug development. Professor Peter ‘t Hart highlights breakthroughs in sustainable peptide synthesis powered by AI-designed molecules that challenge traditional methods. These technologies enable rapid discovery of novel therapeutic candidates targeting complex biological pathways, offering promising directions for treating diseases with improved efficiency and reduced environmental impact.